96 related articles for article (PubMed ID: 23131876)
1. Optimizing the early prediction model for symptomatic remission with short-term treatment for schizophrenia.
Lin CH; Chou LS; Lin CH; Hsu CY; Chen CC; Lane HY
J Clin Psychopharmacol; 2012 Dec; 32(6):773-7. PubMed ID: 23131876
[TBL] [Abstract][Full Text] [Related]
2. Early prediction of clinical response in schizophrenia patients receiving the atypical antipsychotic zotepine.
Lin CH; Chou LS; Lin CH; Hsu CY; Chen YS; Lane HY
J Clin Psychiatry; 2007 Oct; 68(10):1522-7. PubMed ID: 17960966
[TBL] [Abstract][Full Text] [Related]
3. Early prediction of antipsychotic response in schizophrenia.
Correll CU; Malhotra AK; Kaushik S; McMeniman M; Kane JM
Am J Psychiatry; 2003 Nov; 160(11):2063-5. PubMed ID: 14594760
[TBL] [Abstract][Full Text] [Related]
4. Optimizing early prediction for antipsychotic response in schizophrenia.
Chang YC; Lane HY; Yang KH; Huang CL
J Clin Psychopharmacol; 2006 Dec; 26(6):554-9. PubMed ID: 17110810
[TBL] [Abstract][Full Text] [Related]
5. Remission after first-episode schizophrenia: results of a long-term follow-up.
Üçok A; Serbest S; Kandemir PE
Psychiatry Res; 2011 Aug; 189(1):33-7. PubMed ID: 21196051
[TBL] [Abstract][Full Text] [Related]
6. Comparative remission rates of schizophrenic patients using various remission criteria.
Beitinger R; Lin J; Kissling W; Leucht S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1643-51. PubMed ID: 18616969
[TBL] [Abstract][Full Text] [Related]
7. Achieving symptomatic remission in out-patients with schizophrenia--a naturalistic study with quetiapine.
Wobrock T; Köhler J; Klein P; Falkai P
Acta Psychiatr Scand; 2009 Aug; 120(2):120-8. PubMed ID: 19392812
[TBL] [Abstract][Full Text] [Related]
8. Early prediction of antipsychotic nonresponse among patients with schizophrenia.
Leucht S; Busch R; Kissling W; Kane JM
J Clin Psychiatry; 2007 Mar; 68(3):352-60. PubMed ID: 17388703
[TBL] [Abstract][Full Text] [Related]
9. Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial.
Stentebjerg-Olesen M; Ganocy SJ; Findling RL; Chang K; DelBello MP; Kane JM; Tohen M; Jeppesen P; Correll CU
Eur Child Adolesc Psychiatry; 2015 Dec; 24(12):1485-96. PubMed ID: 26032132
[TBL] [Abstract][Full Text] [Related]
10. Percentage reduction of depression severity versus absolute severity after initial weeks of treatment to predict final response or remission.
Lin CH; Chen CC; Wang FC; Lane HY
Psychiatry Clin Neurosci; 2013 May; 67(4):265-72. PubMed ID: 23683158
[TBL] [Abstract][Full Text] [Related]
11. [Double-blind comparison of 3 x 75 mg zotepine und 3 x 4 mg haloperidol in acute schizophrenic patients].
Klieser E; Lehmann E; Tegeler J
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():14-7. PubMed ID: 1683333
[TBL] [Abstract][Full Text] [Related]
12. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
Schennach-Wolff R; Jäger M; Obermeier M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Möller HJ; Riedel M
World J Biol Psychiatry; 2010 Aug; 11(5):729-38. PubMed ID: 20380620
[TBL] [Abstract][Full Text] [Related]
13. One-year functional outcomes of naturalistically treated patients with schizophrenia.
Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
[TBL] [Abstract][Full Text] [Related]
14. Zotepine in the treatment of negative symptoms in chronic schizophrenia.
Fleischhacker WW; Barnas C; Stuppäck C; Unterweger B; Hinterhuber H
Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):58-60. PubMed ID: 2883684
[TBL] [Abstract][Full Text] [Related]
15. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.
Lin CC; Chiu HJ; Chen JY; Liou YJ; Wang YC; Chen TT; Bai YM
J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of zotepine in therapy-refractory psychoses. An open, multicenter study in eight psychiatric clinics].
Harada T; Otsuki S; Fujiwara Y
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():41-4. PubMed ID: 1683339
[TBL] [Abstract][Full Text] [Related]
17. Statistical validation of the criteria for symptom remission in schizophrenia: preliminary findings.
Opler MG; Yang LH; Caleo S; Alberti P
BMC Psychiatry; 2007 Jul; 7():35. PubMed ID: 17650312
[TBL] [Abstract][Full Text] [Related]
18. Predictors of clinical outcome in schizophrenic patients responding to clozapine.
Mauri MC; Volonteri LS; Dell'Osso B; Regispani F; Papa P; Baldi M; Bareggi SR
J Clin Psychopharmacol; 2003 Dec; 23(6):660-4. PubMed ID: 14624196
[TBL] [Abstract][Full Text] [Related]
19. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
[TBL] [Abstract][Full Text] [Related]
20. Reply to comments on "Optimizing early prediction for antipsychotic response in schizophrenia".
Chang YC; Lane HY
J Clin Psychopharmacol; 2009 Aug; 29(4):391. PubMed ID: 19593183
[No Abstract] [Full Text] [Related]
[Next] [New Search]